AKCEA THERAPEUTICS
Dead / Cancelled — Cancelled — Section 8 (as of 21 Mar 2025)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 86480614
- Registration number
- 5561325
- Mark type
- Stylized text
- Filed
- 15 Dec 2014
- Published for opposition
- 09 Jun 2015
- Registered
- 11 Sept 2018
- Attorney of record
- Brian Focarino
Goods and services
- Class 005 — Pharmaceuticals: diagnostic preparations and human therapeutics for raising HDL or the diagnosis and treatment of elevated triglycerides, pancreatitis, dyslipidemia, insulin resistance, metabolic syndrome, diabetes, familial chylomicronemia syndrome, elevated Lp(a), hypertension, inflammation, thrombosis, atherosclerosis, hypercholesterolemia, lipodystrophy, and other cardiovascular, cardiopulmonary, metabolic and inflammatory diseases and disorders
Owner
- AKCEA THERAPEUTICS, INC., Cambridge, MA, US
- IONIS PHARMACEUTICALS, INC., CARLSBAD, CA, US
- IONIS PHARMACEUTICALS, INC., CARLSBAD, CA, US
- Isis Pharmaceuticals, Inc., Carlsbad, CA, US
- Isis Pharmaceuticals, Inc., Carlsbad, CA, US
Prosecution history
- 21 Mar 2025 — CANCELLED SEC. 8 (6-YR)
- 25 Sept 2024 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 25 Sept 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 25 Sept 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 25 Sept 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 25 Sept 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 25 Sept 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 11 Sept 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 29 Jul 2020 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 11 Sept 2018 — REGISTERED-PRINCIPAL REGISTER
- 07 Aug 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 05 Aug 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 30 Jul 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 27 Jul 2018 — USE AMENDMENT FILED
- 27 Jul 2018 — TEAS STATEMENT OF USE RECEIVED